TGaS Advisors, a division of Trinity
Michelle Mayer is currently the Executive Director of Access Strategy and Customer Engagement at TGaS Advisors, a division of Trinity. Prior to this role, Michelle held key positions at RxAdvance PBM, LLC, and Eli Lilly and Company. Throughout their career, Michelle has excelled in various roles such as Regional Managed Markets, Senior Account Director and Executive Sales Representative. Michelle’s expertise extends to the pharmaceutical industry, where Michelle has made significant impacts through effective sales presentations, marketing strategies, and building relationships with key stakeholders. Their background includes experience in drug metabolism research and a strong educational foundation in Biotechnology and Toxicology.
TGaS Advisors, a division of Trinity
TGaS Advisors, a division of Trinity Life Sciences, is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. With a roster of top 50, emerging and precommercial life sciences companies, TGaS provides robust comparative intelligence and collaborative network membership services. The team includes more than 60 experienced professionals, most with senior-level experience in the life sciences and related industries.